S&P 500
(0.12%) 5 254.71 points
Dow J
(0.05%) 39 780 points
Nasdaq
(0.03%) 16 405 points
Oil
(1.68%) $82.72
Gas
(0.52%) $1.727
Gold
(0.99%) $2 234.60
Silver
(0.63%) $24.91
Platinum
(1.37%) $922.15
USD/EUR
(0.27%) $0.926
USD/NOK
(0.70%) $10.84
USD/GBP
(0.07%) $0.792
USD/RUB
(0.22%) $92.64

Realtime updates for Tempest Therapeutics, [TPST]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
BUY
50.00%
return 0.02%
SELL
50.00%
return -3.28%
Last Updated28 Mar 2024 @ 11:54

2.98% $ 3.82

SELL 62005 min ago

@ $4.10

Issued: 14 Feb 2024 @ 09:30


Return: -6.83%


Previous signal: Feb 13 - 09:30


Previous signal: Buy


Return: -0.93 %

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 11:54):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxisome proliferator-activated receptor alpha that is in a Phase 1 trial in solid tumors...

Stats
Today's Volume 192 200
Average Volume 683 475
Market Cap 84.77M
EPS $0 ( 2024-03-27 )
Next earnings date ( $-0.440 ) 2024-05-08
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -2.00
ATR14 $0.0100 (0.26%)
Insider Trading
Date Person Action Amount type
2024-01-03 Brady Stephen R Buy 250 000 Employee Stock Option (right to buy)
2024-01-03 Whiting Samuel Buy 100 000 Employee Stock Option (right to buy)
2024-01-03 Trojanowski Justin Buy 26 500 Employee Stock Option (right to buy)
2024-01-03 Maestas Nicholas Buy 40 000 Employee Stock Option (right to buy)
2023-10-11 Brady Stephen R Buy 725 000 Employee Stock Option (right to buy)
INSIDER POWER
99.68
Last 85 transactions
Buy: 12 322 880 | Sell: 50 340

Volume Correlation

Long: -0.09 (neutral)
Short: -0.75 (moderate negative)
Signal:(52.942) Neutral

Tempest Therapeutics, Correlation

10 Most Positive Correlations
SIFY0.842
SVOK0.816
FORE0.814
10 Most Negative Correlations
RAVN-0.856

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Tempest Therapeutics, Correlation - Currency/Commodity

The country flag -0.70
( moderate negative )
The country flag -0.52
( weak negative )
The country flag 0.00
( neutral )
The country flag -0.68
( moderate negative )
The country flag 0.00
( neutral )
The country flag 0.15
( neutral )

Tempest Therapeutics, Financials

Annual 2023
Revenue: $0
Gross Profit: $-381 000 (0.00 %)
EPS: $-1.910
Q4 2023
Revenue: $0
Gross Profit: $-85 000.00 (0.00 %)
EPS: $-0.350
Q3 2023
Revenue: $0
Gross Profit: $-510 000 (0.00 %)
EPS: $-0.480
Q2 2023
Revenue: $0
Gross Profit: $-497 000 (0.00 %)
EPS: $-0.540

Financial Reports:

No articles found.

Tempest Therapeutics,

Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxisome proliferator-activated receptor alpha that is in a Phase 1 trial in solid tumors. It also develops TREX-1, a key cellular enzyme that regulates the innate immune response in tumors. The company was founded in 2011 and is headquartered in South San Francisco, California. Tempest Therapeutics Inc. was formerly a subsidiary of Inception Sciences, Inc.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators